Ebtesama Hospital
Cairo, 11341, Egypt
NCT Number: NCT05901948
Utilising a novel pre-surgical grading system to class cases of asherman syndrome into 3 groups based on expected difficulty of surgery and potential prognostic outcomes.
Looking for future studies?
Notify Me20 year–40 year
Female
Observational
Cairo, 11341, Egypt
Using the grading system, patients are classified into Mild, Moderate and Severe Asherman Syndrome. With the mild disease having the best prognostic value and a 1 step procedure, Moderate cases having a mediocre prognosis and usually multi-step procedure and Severe cases having a poor prognosis and counseled to other options. This observational study looks at the surgical outcomes following hysteroscopy for cases graded according to the new system to identify the accuracy of the classification in predicting the surgical success and prognostic value.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Novel Asherman Scoring Classification
Time frame: 1 month
assessing the improvement of the cavity of the uterus in hystero-salpingography
Time frame: 3 months
Improvement in patients menstrual cycle
Ebtesama Hospital
Other
Asherman Syndrome: Pre-surgical Grading to Improve Gauge Prognostic Values and Improve Outcomes
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05095597
Asherman Syndrome, Endometrial Atrophy
Valencia, Spain
View Trial DetailsNCT05521932
Asherman Syndrome, Female Urogenital Diseases
Hangzhou, Zhejiang, China
View Trial DetailsNCT03249415
Asherman Syndrome, Endometrial Atrophy
Barcelona, Spain
View Trial DetailsNCT05414760
Asherman Syndrome, Female Urogenital Diseases
Eindhoven, Netherlands
View Trial Details